Skip to main content
SpringerLink
Log in

Overview and Perspectives: Cardiovascular Disease in Racial/Ethnic Minorities in the Era of COVID-19

  • Chapter
  • First Online:
Cardiovascular Disease in Racial and Ethnic Minority Populations

Part of the book series: Contemporary Cardiology ((CONCARD))

  • 412 Accesses

Abstract

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide and a major contributor to preventable deaths. The COVID-19 pandemic has revealed the persistent disparate burden of CVD and associated risk factors seen in racial/ethnic minorities and disadvantaged populations. In the United States, there are clear disparities associated with CVD and risk factors among racial/ethnic populations, especially for non-Hispanic Black and Hispanic/Latino groups. In the United States, Black groups compared to other racial/ethnic groups have a higher prevalence of hypertension (HTN), with associated target organ damage, obesity (especially among Black females), type 2 diabetes (T2D), premature myocardial infarction, heart failure (HF), peripheral arterial disease (PAD), chronic kidney disease (CKD), end renal stage disease (ERSD), and stroke. There has been some progress in reducing health inequalities over the years, but racial/ethnic disparities persist. Research continues to reveal the unique aspects of CVD, especially related to the social determinants of health and the built environment, even more so than potential genetic factors. The various components of this textbook specifically highlight important concepts and emerging data related to the prevention, diagnosis, and treatment of CVD in non-Hispanic Black and Hispanic/Latino Americans. Healthcare is complex and involves social factors, such as available community resources. It is essential that clinicians, researchers, and public health officials use the best available data and the concepts described here-in to tackle the persistent and unacceptable disparities in CVD and associated cardiometabolic risks.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC Jr, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA Sr, Williamson JD, Wright JT Jr. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:e13–e115.

    CAS  PubMed  Google Scholar 

  2. Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC Jr, Sperling L, Virani SS, Yeboah J. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139:e1082–143.

    PubMed  Google Scholar 

  3. Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, Michos ED, Miedema MD, Muñoz D, Smith SC Jr, Virani SS, Williams KA Sr, Yeboah J, Ziaeian B. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 Sep 10;140(11):e596–646.

    PubMed  PubMed Central  Google Scholar 

  4. Keith F, Annemarie A. Cardiovascular disease in racial and ethnic minorities. Dordrecht: Humana Press; 2010.

    Google Scholar 

  5. Divens LL, Chatmon BN. Cardiovascular disease management in minority women: special considerations. Crit Care Nurs Clin North Am. 2019 Mar;31(1):39–47.

    Article  PubMed  Google Scholar 

  6. Pool LR, Ning H, Lloyd-Jones DM, Allen NB. Trends in racial/ethnic disparities in cardiovascular health among US adults from 1999–2012. J Am Heart Assoc. 2017 Sep 22;6(9):e006027.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Glasser SP, Judd S, Basile J, Lackland D, Halanych J, Cushman M, Prineas R, Howard V, Howard G. Prehypertension, racial prevalence and its association with risk factors: analysis of the REasons for Geographic And Racial Differences in Stroke (REGARDS) Study. Am J Hypertens. 2011 Feb;24(2):194–9.

    Article  PubMed  Google Scholar 

  8. Sorlie PD, Allison MA, Avilés-Santa ML, Cai J, Daviglus ML, Howard AG, Kaplan R, LaVange LM, Raij L, Schneiderman N, Wassertheil-Smoller S, Talavera GA. Prevalence of hypertension, awareness, treatment, and control in the Hispanic Community Health Study/Study of Latinos. Am J Hypertens. June 2014;27(6):793–800.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Lamar M, Durazo-Arvizu R, Rodriguez C, Kaplan R, Perera M, Cai J, et al. Associations of lipid levels and cognition: findings from the Hispanic Community Health Study/Study of Latinos. J Int Neuropsychol Soc. n.d.:1–12.

    Google Scholar 

  10. Rubin J, Aggarwal SR, Swett KR, Kirtane AJ, Kodali SK, Nazif TM, Pu M, Dadhania R, Kaplan RC, Rodriguez CJ. Burden of valvular heart diseases in Hispanic/Latino Individuals in the United States: the Echocardiographic Study of Latinos. Mayo Clin Proc. 2019 Aug;94(8):1488–98.

    Article  PubMed  Google Scholar 

  11. Dominguez K, Penman-Aguilar A, Chang MH, Moonesinghe R, Castellanos T, Rodriguez-Lainz A, Schieber R. Vital signs: leading causes of death, prevalence of diseases and risk factors, and use of health services among Hispanics in the United States – 2009-2013. MMWR Morb Mortal Wkly Rep. 2015 May 8;64(17):469–78.

    PubMed  PubMed Central  Google Scholar 

  12. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, Finkelstein EA, Hong Y, Johnston SC, Khera A, Lloyd-Jones DM, Nelson SA, Nichol G, Orenstein D, Wilson PW, Woo YJ. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011 Mar 1;123(8):933–44.

    Article  PubMed  Google Scholar 

  13. Durstenfeld MS, Ogedegbe O, Katz SD, Park H, Blecker S. Racial and ethnic differences in heart failure readmissions and mortality in a large municipal healthcare system. JACC Heart Fail. 2016 Nov;4(11):885–93. https://doi.org/10.1016/j.jchf.2016.05.008. Epub 2016 Jul 6.

  14. Raghavan S, Ho Y-L, Kini V, Rhee MK, Vassy JL, Gagnon DR, Cho K, Wilson PWF, Phillips LS. Association between early hypertension control and cardiovascular disease incidence in veterans with diabetes. Diabetes Care. 2019 Oct;42(10):1995–2003.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Peprah E, Xu H, Tekola-Ayele F, Royal CD. Genome-wide association studies in Africans and African Americans: expanding the framework of the genomics of human traits and disease. Public Health Genomics. 2015;18:40–51.

    Article  PubMed  Google Scholar 

  16. Landry LG, Ali N, Williams DR, Rehm HL, Bonham VL. Lack of diversity in genomic databases is a barrier to translating precision medicine research into practice. Health Aff (Millwood). 2018 May;37(5):780–5.

    Article  Google Scholar 

  17. Mensah GA, Jaquish C, Srinivas P, Papanicolaou GJ, Wei GS, Redmond N, Roberts MC, Nelson C, Aviles-Santa L, Puggal M, Green Parker MC, Minear MA, Barfield W, Fenton KN, Boyce CA, Engelgau MM, Khoury MJ. Emerging concepts in precision medicine and cardiovascular diseases in racial and ethnic minority populations. Circ Res. 2019 June 21;125(1):7–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Friedman PN, Shaazuddin M, Gong L, Grossman RL, Harralson AF, Klein TE, Lee NH, Miller DC, Nutescu EA, O’Brien TJ, O’Donnell PH, O’Leary KJ, Tuck M, Meltzer DO, Perera MA. The ACCOuNT consortium: a model for the discovery, translation, and implementation of precision medicine in African Americans. Clin Transl Sci. 2019 May;12(3):209–17.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Kumanyika S. Obesity treatment in minorities. In: Wadden TA, Stunkard AJ, editors. Handbook of obesity treatment. New York: The Guilford Press; 2002. p. 416–46.

    Google Scholar 

  20. Morris AA, Ko YA, Hutcheson SH, Quyyumi A. Race/ethnic and sex differences in the association of atherosclerotic cardiovascular disease risk and healthy lifestyle behaviors. J Am Heart Assoc. 2018;7(10):e008250.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Shay CM, Spartano NL, Stokes A, Tirschwell DL, VanWagner LB, Tsao CW. Heart disease and stroke statistics-2020 update: a report from the American Heart Association. Circulation. 2020 Jan 29;141:CIR0000000000000757.

    Google Scholar 

  22. Amrock SM, Duell PB, Knickelbine T, Martin SS, O’Brien EC, Watson KE, Mitri J, Kindt I, Shrader P, Baum SJ, Hemphill LC, Ahmed CD, Andersen RL, Kullo IJ, McCann D, Larry JA, Murray MF, Fishberg R, Guyton JR, Wilemon K, Roe MT, Rader DJ, Ballantyne CM, Underberg JA, Thompson P, Duffy D, Linton MF, Shapiro MD, Moriarty PM, Knowles JW, Ahmad ZS. Health disparities among adult patients with a phenotypic diagnosis of familial hypercholesterolemia in the CASCADE-FH™ patient registry. Atherosclerosis. 2017 Dec;267:19–26.

    Article  CAS  PubMed  Google Scholar 

  23. Ference BA, Bhatt DL, Catapano AL, Packard CJ, Graham I, Kaptoge S, Ference TB, Guo Q, Laufs U, Ruff CT, Cupido A, Hovingh GK, Danesh J, Holmes MV, Smith GD, Ray KK, Nicholls SJ, Sabatine MS. Association of genetic variants related to combined exposure to lower low-density lipoproteins and lower systolic blood pressure with lifetime risk of cardiovascular disease. JAMA. 2019 Sep 2;322:1381–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Anderson WA, Greene GW, Forse RA, Apovian CM, Istfan NW. Weight loss and health outcomes in African Americans and Whites after gastric bypass surgery. Obesity (Silver Spring). 2007 June;15(6):1455–63.

    Article  Google Scholar 

  25. Amirian H, Torquati A, Omotosho P. Racial disparity in 30-day outcomes of metabolic and bariatric surgery. Obes Surg. 2019 Nov 19;30(3):1011–20.

    Article  PubMed Central  Google Scholar 

  26. Clark D 3rd, Colantonio LD, Min YI, Hall ME, Zhao H, Mentz RJ, Shimbo D, Ogedegbe G, Howard G, Levitan EB, Jones DW, Correa A, Muntner P. Population-attributable risk for cardiovascular disease associated with hypertension in black adults. JAMA Cardiol. 2019 Oct 23;4:1–9.

    Google Scholar 

  27. Shah KB, Mankad AK, Castano A, Akinboboye OO, Duncan PB, Fergus IV, Maurer MS. Transthyretin cardiac amyloidosis in black Americans. Circ Heart Fail. 2016;9(6):e002558.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, Kristen AV, Grogan M, Witteles R, Damy T, Drachman BM, Shah SJ, Hanna M, Judge DP, Barsdorf AI, Huber P, Patterson TA, Riley S, Schumacher J, Stewart M, Sultan MB, Rapezzi C. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med. 2018 Sep 13;379(11):1007–16.

    Article  CAS  PubMed  Google Scholar 

  29. Duncan L, Shen H, Gelaye B, Meijsen J, Ressler K, Feldman M, Peterson R, Domingue B. Analysis of polygenic risk score usage and performance in diverse human populations. Nat Commun. 2019 July 25;10(1):3328.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Martin AR, Kanai M, Kamatani Y, Okada Y, Neale BM, Daly MJ. Clinical use of current polygenic risk scores may exacerbate health disparities. Nat Genet. 2019 Apr;51(4):584–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Investigators TA of URP. The “all of us” research program. N Engl J Med [Internet]. 2019 Aug 15;381(7):668–76. Available from: https://www.nejm.org/doi/full/10.1056/NEJMsr1809937.

  32. Shahu A, Herrin J, Dhruva SS, Desai NR, Davis BR, Krumholz HM, Spatz ES. Disparities in socioeconomic context and association with blood pressure control and cardiovascular outcomes in ALLHAT. J Am Heart Assoc. 2019 Aug 6;8(15):e012277.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Schwalm JD, McCready T, Lopez-Jaramillo P, Yusoff K, Attaran A, Lamelas P, Camacho PA, Majid F, Bangdiwala SI, Thabane L, Islam S, McKee M, Yusuf S. A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trial. Lancet. 2019 Oct 5;394(10205):1231–42.

    Article  PubMed  Google Scholar 

  34. Glynn P, Lloyd-Jones DM, Feinstein MJ, Carnethon M, Khan SS. Disparities in cardiovascular mortality related to heart failure in the United States. J Am Coll Cardiol. 2019 May 14;73(18):2354–5.

    Article  PubMed  Google Scholar 

  35. Alexander KM, Orav J, Singh A, Jacob SA, Menon A, Padera RF, Kijewski MF, Liao R, Di Carli MF, Laubach JP, Falk RH, Dorbala S. Geographic disparities in reported US amyloidosis mortality from 1979 to 2015: potential underdetection of cardiac amyloidosis. JAMA Cardiol. 2018 Sep 1;3(9):865–70.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Andersson C, Vasan RS. Epidemiology of cardiovascular disease in young individuals. Nat Rev Cardiol. 2018 Apr;15(4):230–40.

    Article  PubMed  Google Scholar 

  37. Mensah GA, Cooper RS, Siega-Riz AM, Cooper LA, Smith JD, Brown CH, Westfall JM, Ofili EO, Price LN, Arteaga S, Green Parker MC, Nelson CR, Newsome BJ, Redmond N, Roper RA, Beech BM, Brooks JL, Furr-Holden D, Gebreab SY, Giles WH, James RS, Lewis TT, Mokdad AH, Moore KD, Ravenell JE, Richmond A, Schoenberg NE, Sims M, Singh GK, Sumner AE, Treviño RP, Watson KS, Avilés-Santa ML, Reis JP, Pratt CA, Engelgau MM, Goff DC Jr, Pérez-Stable EJ. Reducing cardiovascular disparities through community-engaged implementation research: a National Heart, Lung, and Blood Institute workshop report. Circ Res. 2018 Jan 19;122(2):213–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Pandey A, Keshvani N, Ayers C, Correa A, Drazner MH, Lewis A, Rodriguez CJ, Hall ME, Fox ER, Mentz RJ, de Filippi C, Seliger SL, Ballantyne CM, Neeland IJ, de Lemos JA, Berry JD. Association of cardiac injury and malignant left ventricular hypertrophy with risk of heart failure in African Americans: the Jackson Heart Study. JAMA Cardiol. 2019 Jan 1;4(1):51–8.

    Article  PubMed  Google Scholar 

  39. Ferdinand KC, Nasser SA. African-American COVID-19 mortality: a sentinel event. J Am Coll Cardiol. 2020;75(21):2746–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Tulane University School of Medicine, New Orleans, LA, USA

    Adedoyin Johnson, Bradley Deere & Keith C. Ferdinand

Authors
  1. Adedoyin Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bradley Deere
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Keith C. Ferdinand
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Keith C. Ferdinand .

Editor information

Editors and Affiliations

  1. Tulane University School of Medicine, New Orleans, LA, USA

    Keith C. Ferdinand

  2. Cardiovascular Research Institute, Morehouse School of Medicine, Atlanta, GA, USA

    Herman A. Taylor, Jr.

  3. School of Medicine, Albert Einstein College of Medicine, Bronx, NY, USA

    Carlos J. Rodriguez

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Johnson, A., Deere, B., Ferdinand, K.C. (2021). Overview and Perspectives: Cardiovascular Disease in Racial/Ethnic Minorities in the Era of COVID-19. In: Ferdinand, K.C., Taylor, Jr., H.A., Rodriguez, C.J. (eds) Cardiovascular Disease in Racial and Ethnic Minority Populations. Contemporary Cardiology. Humana, Cham. https://doi.org/10.1007/978-3-030-81034-4_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-81034-4_1

  • Published:

  • Publisher Name: Humana, Cham

  • Print ISBN: 978-3-030-81033-7

  • Online ISBN: 978-3-030-81034-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation